Grifols Accused Of Off-Label Drug Uses In FCA Suit
Spanish pharmaceutical company Grifols SA potentially bilked the federal government, 28 states and Washington, D.C., out of millions of dollars by inappropriately marketing unapproved uses of a drug for a rare...To view the full article, register now.
Already a subscriber? Click here to view full article